Celanese Corp (CE US)
CE US$48.32
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 48.32
- Change
- ▼ -0.53 (-1.09)
- Bid / Ask
- 48.30 - 48.32
- Volume
- 444,611
- Turnover
- 18,886,797
- Open
- 48.73
- Day Range
- 47.74 - 49.20
- VWAP
- 48.27
- Prev Close
- 48.85
- Last Trade
- 29/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Basic Materials
- Shares Issued
- 109,748,926
- NTA/Share
- -26.31
- Last Dividend
- 0.03
- Dividend Ex Date
- 28 JUL 2026
- Dividend Pay Date
- 10 AUG 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 9,544.00
- EBITDA
- 243.00
- Profit
- -1,165.00
- Earnings Per Share (EPS)
- -10.64
- Dividend Per Share (DPS)
- 0.12
- Yield %
- 0.25
- Market Cap
- 5,303.07
- Price to Earnings Ratio (P/E)
- -4.56
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 9,640.68
- EBITDA
- 1,851.00
- Profit
- 628.06
- Earnings Per Share (EPS)
- 5.59
- Dividend Per Share (DPS)
- 0.12
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- Narrow
- Financial Health
- Moderate
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 22 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 53.98 Fair value 61.66 One-star price 70.43
Morningstar Quantitative Rating as of 22 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 61.66
- Price / Fair Value
- 0.77
- Valuation
- Undervalued
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 22 OCT 2026. The slider runs from the five-star price (53.98) to the one-star price (70.43).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 47.22 |
| Price - 12 month high | 70.65 |
| Price - 12 month low | 35.49 |
| Pricing date | 21 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 1.44 |
| Market capitalization | 5,182.34 |
| 12 Month High price date | 5 MAY 2026 |
| 12 Month Low price date | 20 NOV 2025 |
| Volume - avg. trading volume for the last 3 months | 1.78 |
| Price - 1 Day % Change | -0.11% |
| Price - 13 week price percent change | -2.36% |
| Price - 26 week price percent change | -27.89% |
| Price - 5 Day % Change | 1.68% |
| Price - 52 week price percent change | 16.77% |
| Price - YTD price percent change | 10.33% |
| Price % Change Month To Date | -0.46% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | -10.440 |
| EPS excluding extraordinary items - trailing 12 month | -10.600 |
| EPS Normalized - most recent fiscal year | 3.980 |
| Revenue/share - most recent fiscal year | 87.136 |
| Revenue/share - trailing 12 month | 88.504 |
| Book value per share - most recent fiscal year | 36.953 |
| Book value per share - most recent quarter | 37.969 |
| Book value (tangible) per share - most recent fiscal year | -26.312 |
| Book value (tangible) per share - most recent quarter | -24.037 |
| Cash per share - most recent fiscal year | 11.527 |
| Cash per share - most recent quarter | 12.428 |
| Cash Flow per share - most recent fiscal year | 8.208 |
| Cash Flow per share - trailing 12 month | 7.965 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.120 |
| EBITD per share - trailing 12 month | 3.891 |
| EPS Basic excluding extraordinary items - most recent fiscal year | -10.440 |
| EPS Basic excluding extraordinary items - trailing 12 month | -10.590 |
| EPS including extraordinary items - most recent fiscal year | -10.640 |
| EPS including extraordinary items - trailing 12 month | -10.680 |
| Free Cash Flow per share - trailing 12 month | 5.450 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | — |
| P/E Normalized, most recent fiscal year | 66.52 |
| Price to sales - most recent fiscal year | 0.53 |
| Price to Tangible Book - most fiscal year | — |
| Price to Free Cash Flow per Share - most recent fiscal year | 8.67 |
| Price to Cash Flow per share - trailing 12 month | 5.93 |
| Price to Book - most recent fiscal year | 1.24 |
| P/E excluding extraordinary items high, trailing 12 months | — |
| P/E excluding extraordinary items low, trailing 12 months | — |
| Net Debt, LFI | 11,033.00 |
| Net Debt, LFY | 11,671.00 |
| Dividend Yield - 5 Year Average | 0.85% |
| Dividend Yield - indicated annual dividend divided by closing price | 0.25% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 0.25% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 556.00 |
| LT debt/equity - most recent fiscal year | 260.71% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 289.22% |
| LT debt/equity - most recent quarter | 240.04% |
| Total debt/total equity - most recent quarter | 270.20% |
| Free Cash Flow - trailing 12 month | 598.00 |
| Payout ratio - trailing 12 month | -0.28% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 9,544.00 |
| Revenue - trailing 12 month | 9,712.00 |
| EBITD - most recent fiscal year | 243.00 |
| EBITD - trailing 12 month | 427.00 |
| Earnings before taxes - most recent fiscal year | -1,220.00 |
| Earnings before taxes - trailing 12 month | -1,123.00 |
| Net Income available to common - most recent fiscal year | -1,165.00 |
| Net Income available to common - trailing 12 months | -1,169.00 |
| Earnings before taxes Normalized - most recent fiscal year | 1,903.00 |
| Net Income Available to Common, Normalized - most recent fiscal year | 437.00 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 0.71 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | -11.84% |
| Net Profit Margin % - trailing 12 month | -11.79% |
| Operating margin - 1st historical fiscal year | 8.01% |
| Operating margin - trailing 12 month | 8.42% |
| Pretax margin - trailing 12 month | -11.56% |
| Pretax margin - 1st historical fiscal year | -12.78% |
| Operating Margin - 5 year average | 13.16% |
| Pretax Margin - 5 year average | 5.79% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 9.99% |
| Free Operating Cash Flow/Revenue, TTM | 6.16% |
| Net Profit Margin - 5 year average | 6.68% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | -4.97% |
| Return on average assets - trailing 12 month | -5.17% |
| Return on average equity - most recent fiscal year | -23.95% |
| Return on average equity - trailing 12 month | -26.62% |
| Return on average assets - 5 year average | 5.10% |
| Return on average equity - 5 year average | 14.87% |
| Net Income/employee - most recent fiscal year | -98,828.06 |
| Revenue/employee - most recent fiscal year | 834,703.52 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 11.03% |
| EPS growth rate, 5 year | — |
| Growth rate% - dividend, 3 year | -64.75% |
| Revenue/share (5 yr growth) | 12.79% |
| Growth rate% - Revenue, 3 year | -0.45% |
| Growth rate% - EPS, 3 year | — |
| Book value per share growth rate, 5 year | 3.65% |
| Capital Spending growth rate, 5 year | -1.18% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | -36.98% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Celanese is a global specialty chemicals manufacturer. It operates in two segments: acetyl chain, and engineered materials. Acetyl chain profitability is exposed to commodity-linked raw materials and product pricing spreads. Engineered materials converts basic chemicals into higher-margin specialty polymers and compounds engineered for specific customer applications in automotive, medical, electronics, and industrial end markets.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
